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The objective of this study was to test whether the temporal patterns of VT recurrences in
patients with implantable cardioverter-defibrillator (ICD) follow a random or a clustered
pattern by mathematical modeling. METHODS: Data analysis was conducted using the
Medtronic Gem DR database of 521 ICD patients. Patients with > 3 spontaneous VT
detections during follow up were studied. The times between consecutive treated VT
detections (inter-event interval) for each patient were compared to an exponential model
of random recurrences and a Weibull model to test for clustering of recurrences.
RESULTS: 71 patients had > 3 VT episodes during a mean follow-up of 131 days. A total
of 2347 VT episodes were recorded (33+65 episodes/patient, median 10 episodes /
patient). Patient age 66+13 years, 78% male, 83% coronary artery disease, ejection frac-
tion 31+11%, 63% taking antiarrhythmic drugs. The inter-event interval was less than 1
hour for 78% of all intervals and was less than 91 hours for 94% of inter-event intervals.
By the Kolmogorov Smirnov goodness-of-fit test, 38 out of 71 patients (53.5%) showed
that the distribution of inter-detection intervals differed from an exponential model (p <
0.01 for each patient, p = 0.65 for proportion of patients similar to chance), while only 11
out of 71 patients (15.5%) showed that the distribution of inter-detection intervals differed
from a Weibull model (p < 0.01 for each patient, p < 0.001 for proportion of patients simi-
lar to chance). CONCLUSION: The recurrence pattern of treated VT events in ICD
patients are clustered and are more frequently described by a Weibull distribution than a
random distribution. The time between consecutive treated VT detections is usually < 1
hour and infrequently > 91 hours. Knowledge of this pattern may help to design studies of
new antiarrhythmic therapies.
1053-213 The Predictive Value of Electrophysiologic Testing: 
Subgroup Analysis in the Dual Chamber and VVI 
Implantable Defibrillator (DAVID) Trial
Nicholas G. Tullo, Anil K. Bhandari, Anne H. Dougherty, G. Stephen Greer, Maribel 
Hernandez, Gregory Michaud, Alfred Hallstrom, Anna O. Leonen, Ellen G. Renfroe, and 
the DAVID Investigators, University of Washington, Seattle, WA
Background: The DAVID Trial evaluated whether dual-chamber pacing was superior to
single chamber pacing in patients (pts) with an ejection fraction of less than 40% who
were receiving an implantable cardioverter-defibrillator (ICD). The result of a baseline
electrophysiologic study (EPS) in trial pts was reviewed to determine if inducibility of ven-
tricular arrhythmias predicted outcome.
Methods: A total of 506 pts were enrolled in the DAVID Trial. Baseline EPS was recom-
mended but not required except for pts enrolled because of unexplained syncope. The
induction protocol involved up to 3 premature extrastimuli at 2 drive cycle lengths from up
to 2 sites in the right ventricle. Induced arrhythmias were classified based on morphology,
rate, and duration.
Results: Of the pts enrolled in the trial, 313 had a baseline EPS. A comparison of demo-
graphic and clinical parameters between the pts who underwent EPS and those who did
not revealed few substantial differences. At the time of EPS 81% of pts were on drug
therapy, including 60% who were on beta blockers, 29% on digoxin, 10% on calcium
blockers, and 15% on Class I or III antiarrhythmic drugs. The worst arrhythmia induced
was sustained VF in 40 pts, sustained monomorphic VT > 250 bpm in 72 pts, sustained
monomorphic VT 201-250 bpm in 106 pts, sustained monomorphic VT 150-200 bpm in
34 pts, sustained monomorphic VT < 150 bpm in 10 pts, sustained polymorphic VT in 31
pts, non-sustained polymorphic VT in 5 pts, non-sustained monomorphic VT in 3 pts,
less than 15 beats of VT in 3 pts, and no VT in 9 pts. Kaplan-Meier survival analysis
showed no significant difference between inducibility or non-inducibility of the rhythm
classifications with respect to the time to first recurrent arrhythmia, time to first inappro-
priate therapy or time to first re-hospitalization, but time to the primary endpoint (death or
hospitalization for congestive heart failure) was shorter for non-inducible patients and
longest for patients with VF or polymorphic VT induced (p=.01).
Conclusion: In the DAVID pts who underwent EPS, inducibility of VT/VF appears to pre-
dict outcome with regard to survival / hospitalization for heart failure, but not for future
ICD therapies or hospitalization in general.
POSTER SESSION
1071 
Pulmonary Vein Isolation to Treat Atrial 
Fibrillation II
Monday, March 08, 2004, 9:00 a.m.-11:00 a.m.
Morial Convention Center, Hall G
Presentation Hour: 10:00 a.m.-11:00 a.m.
1071-207 Expedited Geometric Rendering of Left Atrium and 
Pulmonary Veins Using Multipoint Electroanatomical 
Mapping
Martin D. Lowe, Laurie A. Peterson, Douglas L. Packer, Mayo Clinic, Rochester, MN
Background: Conventional electroanatomic mapping of the left atrium (LA) and pulmo-
nary veins (PVs) can be both time-consuming and laborious. An accelerated mapping
capability with simultaneous acquisition of multiple points would be clearly advantageous
in facilitating AF ablation.
Methods: We compared integrated multipoint electroanatomical mapping and geometric
rendering of LA and PVs with tip mapping alone in 17 patients undergoing AF ablation.
Eight patients (3 paroxysmal, 5 persistent AF) underwent mapping of LA and each PV
with a multipolar catheter (QwikStar, Biosense), that allowed simultaneous acquisition of
tip, shaft and trace point data from its distal 6 cm. Nine patients who underwent tip map-
ping alone (NaviStar, Biosense), were used as controls. Study patients had an ejection
fraction of 48 ± 16 %, an LA size of 44 ± 3 mm, and had failed 3.1 ± 1.3 antiarrhythmic
drugs, all values similar to controls.
Results: The LA was mapped and geometrically rendered much faster in study patients
than controls (11 ± 5.8 vs. 23 ± 12 minutes). In addition, multipoint mapping with 53 ± 29
tip, 83 ± 31 shaft and 84 ± 117 trace points required less catheter manipulation than con-
trol patients where 111 ± 57 tip points were needed for adequate rendering of LA anat-
omy. In study patients PV mapping required 3.5 ± 2.1 minutes with the LSPV rendered
using 22 ± 7 tip points and 76 ± 41 shaft points, LIPV 25 ± 8 and 69 ± 43, RSPV 24 ± 6
and 49 ± 36, and RIPV 20 ± 6 and 44 ± 30, tip and shaft points. PV trace points were not
required to obtain optimal venous geometry. In controls PVs were mapped in 3.4 ± 2.8
minutes per vein with 62 ± 28 tip points. Although PV mapping times were similar in both
groups, simultaneous multipoint mapping required less catheter movement and tip point
acquisition. The greater number of points in LA and PVs obtained in the study group
allowed for a more qualitatively precise geometric rendering of LA and PVs with clearer
demarcation of PV ostia.
Conclusion: This study demonstrates substantial reduction in LA mapping time by inte-
grated tip and shaft point mapping. The creation of a more anatomically correct rendering
of the LA-PV junction may facilitate ablative intervention, with improved targeting of
energy delivery.
1071-208 Circumferential and Combined Technique in 
Cryoisolation of Pulmonary Veins: The "Arctic Circler" 
Experience
Juergen Vogt, Johannes Heintze, Helga Buschler, Peter Schwartze, Dieter Horstkotte, 
Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Discrete sequential single pulsed isolation of the pulmonary veins (PV) with radiofre-
quency (RF) or cryotechnique with a 6-mm tip catheter is associated with many ostial
impulses and in RF with the risk of PV stenoses.
Guided by a 20-pole Lasso catheter before and after ablation, proximal PV isolation was
performed using the self-expanding arctic circler (AC) with a maximum of 30 mm in diam-
eter over 4 minutes of cryoimpulses (CI) at a temperature of -75 °C to -90°C (with N2O
cryo technique). Electrical gaps were closed under Lasso guidance using a 6-mm tip cry-
ocatheter (freezor xtra, Cryocath, Canada).
Of 35 patients (P) (9 women, age 59±7 years refractory to antiarrhythmic therapy, 33 with
paroxysmal, 2 with persistent atrial fibrillation (AF), mean duration 87±70 months) 22
were treated in a first attempt, 13 after ablation 3 months ago because of AF recurrence.
Of 125 PV 15 were re-isolated with the 6-mm tip cryocatheter because of single or few
inputs only. One hundred and ten PV were isolated with the arctic circler alone in 54%
(59 PV), with additional gap closing by the freezor in 46% (51 PV). Gap closing was more
(70%) required in the left upper PV (Table). There were no acute PV stenoses nor
stenoses after 3 months.
Conclusion: AC isolation of PV is successful in 54% with few CI only and in 100% with
additional gap closing with a conventional cryoablation.
1071-219 Remodeling of the Left Atrium and Pulmonary Veins 
Following Catheter Ablation of Atrial Fibrillation
Darshan Dalal, Vinod Jayam, Chandrasekhar R. Vasamreddy, Lars Lickfett, Dave 
Bradley, Zayd Eldadah, Timm Dickfeld, Henry Halperin, Ronald Berger, Hugh Calkins, 
Johns Hopkins University School of Medicine, Baltimore, MD
Background: Catheter ablation of atrial fibrillation (AF) has been shown to be a curative
approach for treatment of AF. The purpose of this study was to determine to what extent
catheter ablation of AF results in reverse remodeling of left atrial and pulmonary vein
(PV) size.
Methods: The patient population was comprised of 54 patients (40 male, 54+11 years)
who underwent catheter ablation for AF. Each patient had a gadolinium enhanced mag-
netric resonance scan prior to and 6-8 weeks following ablation. The diameters of the
PVs and the oblique axial, coronal, and sagital dimensions of the left atrium were deter-
mined. The left atrial volume was then calculated.
Results: The mean ± SD decrease in LA Volume was 12 ± 22% (p<0.001). The mean ±
SD decrease (mm) in the PV diameter was from 18.1 ± 2.9 to 16.6 ± 3.1 in Left Superior
(LS) PV, 17.5 ± 3.2 to 15.4 ± 4.0 in Left Inferior (LI) PV, 19.5 ± 3.5 to 17.1 ± 4.1 for Right
Superior (RS) PV and 19.0 ± 3.8 to 17.8 ± 4.3 in Right Inferior (RI) PV (p<0.01 for each).
LA volume change had a linear correlation with the reduction in diameter of each of the
four PVs. Percent change in diameter of each PV ostium showed correlation with percent
change in diameter of the other ostia except for LSPV and RIPV (figure). Overall, percent
change in diameter of ostia of all PVs correlated with the percent change in LA volume
(p<0.01).
Tab. 1
Targeted PV Cryoimpulses 
with AC
Isolation AC Isolation
AC + 
Freezor
Cryoimpulses 
Freezor
Isolation
%
Diameter
mm
Left upper (n=31) 5.4±1.6 11 (30%) 20 6.4±5 100 18±4
Left lower (n=23) 3.6±1.1 15 (65%) 8 5.0±2 100 17±2
Right upper (n=29) 4.4±1.4 17 (58%) 12 5.0±3 100 17±3
Right lower (n=27) 3.3±0.9 16 (59%) 11 4.0±2 100 17±3
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Conclusion: The results of this study demonstrate that catheter ablation of AF results in
reverse remodeling of both the LA volume as well as the PV orifices.
1071-220 Initial Results of Anatomical Pulmonary Vein Isolation 
for Atrial Fibrillation
Chandrasekhar R. Vasamreddy, Timm Dickfeld, Vinod Jayam, Zayd Eldadah, Lars 
Lickfett, David Bradley, Hugh Calkins, Johns Hopkins School of Medicine, Baltimore, MD
Background: Anatomical pulmonary vein (PV) isolation has recently been described as
an effective ablation strategy for treatment of atrial fibrillation (AF). These results are
mainly based on a large single-center experience and have yet to be validated by other
centers. The purpose of this study was to report our experience with an anatomically
based ablation strategy..
Methods: Twenty consecutive patients (11 men age 56 + 10 years) underwent anatomi-
cal isolation of the PVs guided by a three-dimensional mapping system (CARTO, Bio-
sense). Each patient had symptomatic drug refractory paroxysmal (2 patients), persistent
(6 patients) or permanent (12 patients) AF. MRI was obtained before and 2-month after
ablation to monitor for PV stenosis. Procedure success was assessed at 3-months fol-
low-up using subjective arrhythmia burden, symptoms, ECG, and Holter monitoring.
Results: Baseline MRI showed abnormal PV anatomy in two patients (left common vein
in one and roof vein in the other). Anatomical PV isolation was successfully performed in
all patients without any immediate complications. The average total procedure, antero-
posterior, and lateral fluoro times were 291+62, 67+18, and 64+20 minutes respectively.
Thirteen out of the total 20 patients completed 3-months follow-up. Ten of these 13
patients (77%) were free of AF and on no antiarrhythmic medications. One (8%) had sig-
nificant improvement in AF and two (15%) failed the procedure. Mild pulmonary stenosis
(< 50%) was observed in 2 patients.
Conclusion: Anatomical PV isolation appears to be a safe and effective ablation strategy
in the treatment of AF.
1071-221 Prevalence of Asymptomatic Recurrences of Atrial 
Fibrillation After Successful Radiofrequency Catheter 
Ablation
Srikar Veerareddy, Hakan Oral, Eric Good, Burr Hall, Peter Cheung, Kristina Lemola, 
Jihn Han, Kamala Tamirisa, Aman Chugh, Frank Pelosi, Jr., Fred Morady, University of 
Michigan, Ann Arbor, MI
Background: The long-term efficacy of radiofrequency catheter ablation of atrial fibrilla-
tion (AF) has been based on patient-reported symptoms suggestive of AF. However,
asymptomatic recurrences of AF may remain undetected. The purpose of this study was
to determine the prevalence of asymptomatic recurrences of AF after an apparently suc-
cessful catheter ablation procedure for AF. Methods: Among 211 consecutive patients
(age= 53±11 yrs) with symptomatic paroxysmal AF who underwent a catheter ablation
procedure for paroxysmal AF and who reported no symptoms of recurrent AF, 47 (22%,
age=53±8 yrs) were randomly selected at least 6 month post-procedure. Pre-ablation,
these patients had experienced 17±13 episodes of AF/ month. Patients were provided
with an event recorder for 30 days, a mean of 545±178 days after the ablation procedure.
Patients were asked to record and transmit at least 1 recording per day and also when-
ever they felt palpitations. The rhythms were analyzed by 2 independent investigators.
Results: Seven patients felt palpitations during the study, although they had not had
symptoms previously. Each of these 7 patients had an episodes of AF documented with
the event monitor during symptoms. Among the remaining 40 patients who had no symp-
toms, an episode of AF was captured in 2 (5%) during routine daily monitoring. One of
these patients also had atrial flutter. However, the mean number of episodes per month
was markedly lower(2) after than before the ablation (30). The duration of these episodes
were 1 and 10 min. Conclusions: Asymptomatic recurrences of AF after an apparently
successful catheter ablation procedure for symptomatic paroxysmal AF occur infre-
quently. These asymptomatic episodes appear to be shorter in duration and less frequent
than before the ablation, and may not necessarily exclude a clinically satisfactory out-
come. However, extended monitoring may be necessary to precisely determine the effi-
cacy of ablation procedures for AF.
1071-222 Relationship of Ostial Pulmonary Vein Diameter to 
Hypertension and Left Ventricular Hypertrophy in 
Patients With Atrial Fibrillation
Bengt Herweg, Tina C. Sichrovski, Luiza Petre, Leo Polosajian, Jonathan S. Steinberg, 
St. Luke's Roosevelt Hospital, New York, NY, University of South Florida, Tampa, FL
Background: Increased ostial pulmonary vein (PV) diameter has been reported in
patients with atrial fibrillation (AF). It remains unclear whether increased PV diameter is a
consequence of AF or due to a noncompliant left ventricle. The purpose of this study was
to investigate the relationship between history of hypertension (HTN), and presence of
left ventricular hypertrophy (LVH) relative to ostial PV diameter in patients with AF.
Methods: We measured the ostial diameter of 324 PVs in 100 patients undergoing PV
isolation procedure for AF by intra-cardiac ultrasound (ICUS), PV angiography, and pre-
operative spiral CT. Diameter measurements of all PVs were compared between patients
without HTN or LVH (n=55), with HTN but no LVH (n=34), or with HTN and LVH (n=11) on
2D echocardiogram. Data are displayed as mean±SEM.
Results: summarized in the table (*p<0.02 compared to no HTN or LVH). Ostial diameter
between individual PVs correlated (r=0.24-0.54, p<0.01). Left atrial dilatation was associ-
ated with larger PV diameter by spiral CT (1.54±0.03 vs. 1.46±0.03, p<0.05).
Conclusion: HTN and LVH are associated with increased ostial PV diameter by all imag-
ing modalities in patients with AF, suggesting that clinical conditions that create a non-
compliant left ventricle may facilitate stretch-induced arrhythmogenesis.
1071-223 Ablation of Superior Pulmonary Veins Compared to 
Ablation of All Four Pulmonary Veins: A Randomized 
Clinical Trial
Demosthenes Katritsis, Kenneth Ellenbogen, Demosthenes B. Panagiotakos, Eleftherios 
Giazitzoglou, Elias Karabinos, Anastasios Papadopoulos, Constantinos Zambartas, 
Constantine Anagnostopoulos, Athens Euroclinic, Athens, Greece, Medical College of 
Virginia, Richmond, VA
OBJECTIVES: To compare a superior pulmonary veins (PVs) isolation approach with
isolation of all PVs for the treatmet ofparoxysmal atrial fibrillation (PAF).
BACKGROUND: Isolation of all PVs is advocated for PAF. However, the superior PVs are
responsible for most AF triggers whereas the inferior PVs carry the higher risk for abla-
tion-induced ostial stenosis.
METHODS: Fifty-two patients with PAF were randomized to either LSPV isolation fol-
lowed by additional isolation of the RSPV in case of AF recurrence (group A, n=27) or
isolation of all four PVs followed by a repeat procedure in case of recurrence (group B,
n=25).
RESULTS: Thirteen of the 27 patients (48%) in group A and 8 of 25 patients (32%) in
group B had AF recurrence within 3 months (p = 0.85 ). Five of the patients with AF
relapse in Group A underwent ablation of the RSPV and 4 of them additional re-ablation
of the LSPV, whereas 3 patients with AF relapse in Group B underwent a repeat proce-
dure. At 1 year follow-up, 11 patients (41%) in Group A and 8 patients (32%) in Group B
had AF relapse (p = 0.55). No significant differences in AF relapse were detected
between groups at 3 and 12 months (log-rank=0.36, p = 0.54) and by Cox-proportional
hazards model analysis (p=0.62). Non-significant PV stenosis was detected in 2 patients
of group B. Total radiofrequency energy delivery, and fluoroscopy and procedure time
were lower in group A: 8.9±1.4 min vs 25.6±3.7 min (p<0.001), 22.2±6.8 min vs 62±10.3
min (p<0.001), and 131.8±26.5 min vs 222.2±32.3 min (p<0.001), respectively.
CONCLUSIONS: A staged PVs isolation approach by targeting the LSPV and RSPV
confers equal success rates but with reduced radiofrequency energy delivery, and fluo-
roscopy and procedure time compared to isolation of all PVs at the initial ablation
attempt.
1071-224 Percutaneous Cryothermic Pulmonary Vein Isolation for 
the Treatment of Atrial Fibrillation: Impact of Specific 
Catheter Design
Tom Wong, Vias Markides, Nicholas S. Peters, D. Wyn Davies, St. Mary's Hospital and 
Imperial College, London, United Kingdom
Background
Conventional ablation catheters were originally designed to generate lesion to destroy a
localized substrate such as in the Wolf-Parkinson-White syndrome. Creating segmental
or circumferential lesions using such catheter can be cumbersome. We therefore exam-
ined the impact of evolving cryoablation catheter design on the feasibility, efficacy, and
safety of pulmonary vein (PV) isolation using cryoablation.
Methods
We performed 60 PV isolation procedures in 51pts (23M, 54.7±10.4 yrs) with symptom-
atic drug refractory paroxysmal (43pts), or persistent (8pts) AF, using conventionally
designed catheters either with a 4mm-tip (Freezor™, n=27, group 1), or a 6mm-tip (Free-
PV Diameter (cm)
no HTN or LVH
(n=55)
HTN but no LVH
(n=34)
HTN and LVH
(n=11)
ICUS 1.56 ± 0.04 1.80 ± 0.06* 1.91 ± 0.13* p<0.001
Angiogram 1.67 ± 0.04 1.81 ± 0.06* 2.10 ± 0.16* p<0.01
Spiral CT 1.43 ± 0.02 1.55 ± 0.03* 1.59 ± 0.06* p<0.01
